During Friday’s Morning trade, Shares of Federated National Holding Co (NASDAQ:FNHC), gained 0.48% to $29.56.
Moments ago, Trader’s Choice released new research updates concerning several important developing situations counting the following equities: JA Solar Holdings Co Ltd (ADR) (JASO),Overstock.com Inc (OSTK), Federated National Holding Co (FNHC) and Ultratech Inc (UTEK). Trader’s Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Highlights from recently’s reports comprise:
On Monday, November 09, 2015, NASDAQ ended at 5,095.30, down 1.01%, Dow Jones Industrial Average declined 1.00%, to finish the day at 17,730.48, and the S&P 500 closed at 2,078.58, down 0.98%.
- JA Solar Holdings Co Ltd’s stock edged higher by 1.05% to close Monday’s session at USD 8.66. The company’s shares oscillated between USD 8.50 and USD 8.77. The stock recorded a trading volume of 0.38 million shares, which was below its 50-day daily average volume of 0.67 million shares and below its 52-week average volume of 1.45 million shares. Over the last three days, JA Solar Holdings Co Ltd’s shares have declined by 0.57%. However, over the last three months, the stock has gained 10.46%. On a compounded total return basis, the company has returned 2.97% in the past one month. Further, the company is trading at a price to earnings ratio of 6.71 and a price to book ratio of 0.48. This compares to a historical PE ratio of 6.91 and PB ratio is of 0.48. Additionally, the stock is trading at a price to cash flow ratio of 2.56 and price to sales ratio of 0.23.
- The stock of Overstock.com Inc lost 3.74% to close Monday’s session at USD 17.00. The shares of the company moved in the range of USD 16.07 and USD 17.67. A trading volume of 0.40 million shares was recorded, which was greater than its 150-day daily average volume of 0.14 million shares and above its 52-week average volume of 0.15 million shares. The stock is trading at a price to earnings ratio of 56.12 and a price to book ratio of 3.23. Further, the stock is trading at a price to cash flow ratio of 11.38 and price to sales ratio of 0.27. Over the last five days, Overstock.com Inc’s shares have advanced 4.74%. However, over the last three months, the stock has declined 22.48%. The stock yielded a negative return of 1.90% in the past one month, on a compounded total return basis. Additionally, the company has a Relative Strength Index (RSI) of 54.29.
Federated National Holding Company, through its auxiliaries, engages in insurance underwriting, distribution, and claims processing in the United States. The company underwrites homeowners multi-peril, commercial general liability, federal flood, workers compensation, personal and commercial automobile, fire, allied lines, and various other lines of insurance, in addition to sells personal umbrella policies. It markets and distributes its own and third-party insurers products and its other services through a network of independent agents.
Shares of Pulmatrix Inc (NASDAQ:PULM), declined -0.22% to $4.58, during its current trading session.
Pulmatrix, reports third quarter financial results and provides an update on the progress year to date on the business and its drug development pipeline. Since the starting of the third quarter, the Company has achieved the following milestones:
- Accomplished formulation of clinical candidates for a planned European pharmacokinetic bioequivalence study of PUR0200, in chronic obstructive pulmonary disease;
- Stated Phase 1b clinical data on PUR0200 demonstrating it was well tolerated and achieved noteworthy lung function improvement over a 24 hour period relative to placebo and comparable effects to the marketed reference product using a fraction of the active pharmaceutical ingredient;
- Stated that PUR1900 was active and potent in in vitro preclinical models against Aspergillus fumigatus, a common fungal infection in Cystic Fibrosis, while achieving high lung concentrations and low systemic exposure in in vivo preclinical models;
- Declared that the partnership with Celdara, Inc. to develop an iSPERSE formulation of a novel biologic, CM-YJH01, was awarded a three-year, $1.7 million NIH Research grant to fund development of an inhaled treatment for idiopathic pulmonary fibrosis (IPF); and
- Further strengthened the Company’s patent portfolio through the receipt of a composition of matter patent related to the iSPERSE™ technology.
“During the third quarter, we made progress across our development pipeline of inhaled therapeutics,” said Robert W. Clarke, Ph.D., chief executive officer of Pulmatrix. “In 2016, we expect to report data from the European bioequivalence study of our branded generic for COPD and start clinical testing for what could become the first inhaled treatment for fungal infections in patients with Cystic Fibrosis. Lastly, as part of our efforts in IPF, we have selected our internal candidate for IND-enabling studies and, through our partnership with Celdara, continued preclinical formulation studies for a novel biologic aimed at preventing epithelial cell death.”
Pulmatrix, Inc., a clinical stage biopharmaceutical company, engages in developing inhaled therapies to address serious pulmonary diseases using its iSPERSE technology. The company’s proprietary product pipeline focuses on advancing treatments for rare diseases, counting PUR1900, an inhaled anti-fungal for patients with cystic fibrosis, in addition to PUR1500, an inhaled product for the treatment of idiopathic pulmonary fibrosis.
Finally, Shares of American Electric Technologies, Inc. (NASDAQ:AETI), gained 2.41%, and is now trading at $3.39.
American Electric Technologies, declared that Mark Haubert has joined the company as Senior Vice President, Sales and Marketing for its flagship M&I Electric business.
Mr. Haubert brings with him more than 25 years of sales, marketing, engineering, operations and executive leadership experience in the energy industry.
In this role, Mr. Haubert will have global responsibility for leading the company’s planned and tactical sales and marketing initiatives targeting the oil & gas, power generation and distribution, marine and industrial segments.
Mr. Haubert was most recently Senior Vice President of Sales and Marketing for EMS USA, Inc., a privately held firm offering pipeline and facility construction, pipeline integrity maintenance, production measurement and automation services to the midstream, upstream and downstream markets. Preceding to EMS, Mr. Haubert was Executive Vice President of Sales, Marketing and Engineering at Express Energy Services where he led noteworthy revenue growth and market penetration with a blue chip customer base. Mr. Haubert has also held a variety of roles at Baker Hughes, Cameron, and Schlumberger.
American Electric Technologies, Inc. provides power delivery solutions to the energy industry in the United States and internationally. The company operates through two segments, the Technical Products and Services (TP&S) and the Electrical and Instrumentation Construction (E&I).